140
Downloads
11
Episodes
Biotech, TechBio and Life Science investors can seem a mysterious crew to those who encounter them - come behind the curtain and learn about the view from their side of the negotiating table. Tom Froggatt, CEO of Singular, shares his conversations with angel investors, VCs and others who are active in the human health sector, as they discuss the fundraising market, how they assess investments, the mistakes they see and their advice for those heading out to raise money to save the lives of patients. Come and see what it’s like on the other side of the table....
Episodes
Thursday Dec 14, 2023
Thursday Dec 14, 2023
This time around on The Other Side of The Table, come with me to meet Uzma Choudry, Biotech/TechBio investment lead at Octopus Ventures.
Uzma built Octopus' TechBio desk and is an active investor and board member at several Biotech and TechBio companies - if you've spent any time on the UK Bio networking scene, you may well have come across her.
There aren't many people who know the space better, and Uzma's insights on how to leverage your existing investors when you pitch, why you should spend more time pursuing grant funding and the drivers of the current market are essential for anyone out raising money.
Come join us for this and a whole lot more!
Thursday Dec 07, 2023
Thursday Dec 07, 2023
Next up on The Other Side of The Table, I'm joined by Gian Seehra.
Gian founded two successful Biotech companies, raising c. $16m along the way, before heading into the world of VC. During his time at QVentures and Octopus Ventures, he invested into Healthtech and Life Sciences companies, and now runs a business helping Seed to Series B founders secure investment.
Across his career on both sides of the table, Gian's been directly involved in over $350m worth of investment, so tune in to hear his insight on tapping into the emotional psychology of investors, how VC KPIs influence the market, and more...
Thursday Nov 30, 2023
Thursday Nov 30, 2023
On this first episode of The Other Side of the Table, I'm with Jason Foster.
Jason is a seasoned entrepreneur, investor and Biotech CEO with an amazing track record on both sides of the funding table, including a very impressive $100m Series B with his current company, Ori Biotech.
His insight into the drivers of the current fundraising climate and his practical tips for those raising money are invaluable - come join us to hear more....